Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries

BACKGROUND: Fremanezumab (TEV-48125) is a fully humanized anti-calcitonin gene-related peptide (CGRP) monoclonal antibody (mAb) that has shown positive results in the prevention of episodic migraine and chronic migraine. Previous preclinical studies have revealed CGRP antagonistic effects on intracr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohlsson, Lena, Kronvall, Erik, Stratton, Jennifer, Edvinsson, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091427/
https://www.ncbi.nlm.nih.gov/pubmed/30109438
http://dx.doi.org/10.1186/s10194-018-0905-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091427/
https://www.ncbi.nlm.nih.gov/pubmed/30109438
http://dx.doi.org/10.1186/s10194-018-0905-8

Ejemplares similares